Dietary Nut and Legume Intake and Risk of Crohn's Disease and Ulcerative Colitis

被引:0
作者
Lopes, Emily W. [1 ,2 ]
Yu, Zeling [1 ]
Walsh, Shawna E. [3 ]
Casey, Kevin [2 ]
Ananthakrishnan, Ashwin N. [1 ,2 ]
Richter, James M. [1 ]
Burke, Kristin E. [1 ,2 ]
Chan, Andrew T. [1 ,2 ,4 ]
Khalili, Hamed [1 ,2 ,4 ,5 ]
机构
[1] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[5] Broad Inst & Harvard, Cambridge, MA USA
基金
美国国家卫生研究院;
关键词
Crohn's disease; ulcerative colitis; inflammatory bowel disease; nutrition; body mass index; MEDITERRANEAN DIET; GUT MICROBIOME; HEART-DISEASE; CONSUMPTION; ASSOCIATIONS; VALIDITY; ADULTS;
D O I
10.1093/ibd/izaf032
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: We investigated the relationship between nut and legume intake and risk of Crohn's disease (CD) and ulcerative colitis (UC). Methods: We conducted a prospective cohort study of 223 283 adults from the Nurses' Health Study (NHS), NHSII, and Health Professionals Follow-Up Study (1986-2017), excluding those with inflammatory bowel disease (IBD) at baseline. Food frequency questionnaires were used to calculate nut and legume intake. Inflammatory bowel disease was self-reported on questionnaires and confirmed via blinded record review. Using Cox proportional hazards models, we calculated adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for CD and UC according to categories of nut and legume intake. Results: In over 5 460 315 person-years of follow-up (CD = 371, UC = 481), neither nut nor legume intake was associated with CD or UC risk. Compared to those who never consumed nuts, those who consumed nuts >= 2 times/week had an aHR = 0.96 (95% CI, 0.63-1.47; P-trend = 0.57) for CD and 1.30 (95% CI, 0.92-1.84; P-trend = 0.36) for UC. Compared to those who consumed legumes 0-3 times/month, those who consumed legumes >= 4 times/week had an aHR of 1.26 (95% CI, 0.78-2.04; P-trend = 0.59) for CD and 0.72 (95% CI, 0.44-1.18; P-trend = 0.20) for UC. Baseline BMI modified the relationship between nut intake and CD risk (P-int = 0.03). In those with BMI >= 25, the aHR for CD was 0.14 (95% CI, 0.03-0.56; P = .006) per additional serving/day of nuts compared with 0.88 (95% CI, 0.45-1.74; P = .72) for those with BMI <25. Conclusions: Nut and legume intake were not associated with CD or UC risk. However, higher nut intake decreased CD risk in overweight or obese individuals. Thus, personalized-risk stratification, rather than generalized dietary recommendations, may be important for IBD prevention strategies. Lay Summary Here, we show that overall nut and legume intake was not associated with risk for development of IBD; however, higher nut intake decreased Crohn's disease risk in those with elevated body mass index.
引用
收藏
页数:9
相关论文
共 50 条
[41]   Crohn's Disease after Proctocolectomy and IPAA for Ulcerative Colitis [J].
Hercun, Julian ;
Cote-Daigneault, Justin ;
Lahaie, Raymond G. ;
Richard, Carole ;
Wassef, Ramses ;
Poitras, Pierre .
DISEASES OF THE COLON & RECTUM, 2021, 64 (02) :217-224
[42]   Comparative study on the pathogenesis of Crohn's disease and ulcerative colitis [J].
Yang, Qi-Hang ;
Zhang, Chuang-Nian .
WORLD JOURNAL OF GASTROENTEROLOGY, 2025, 31 (19)
[43]   Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis [J].
Vilela, Eduardo Garcia ;
da Gama Torres, Henrique Osvaldo ;
Martins, Fabiana Paiva ;
de Abreu Ferrari, Maria de Lourdes ;
Andrade, Marcella Menezes ;
da Cunha, Aloisio Sales .
WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (09) :872-881
[44]   Historical Perspectives: Malignancy in Crohn's Disease and Ulcerative Colitis [J].
Williams, Hannah ;
Steinhagen, Randolph M. .
CLINICS IN COLON AND RECTAL SURGERY, 2024, 37 (01) :5-12
[45]   Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease [J].
Yarani, Reza ;
Shojaeian, Ali ;
Palasca, Oana ;
Doncheva, Nadezhda T. ;
Jensen, Lars Juhl ;
Gorodkin, Jan ;
Pociot, Flemming .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[46]   Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn's disease? [J].
Gilroy, Leah ;
Allen, Patrick B. .
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2014, 7 :163-172
[47]   The Risk of Elective Abortion in Women With Crohn's Disease and Ulcerative Colitis: A Nationwide Cohort Study [J].
Norgard, Bente Mertz ;
Magnussen, Bjarne ;
Fedder, Jens ;
de Silva, Punyanganie S. ;
Wehberg, Sonja ;
Friedman, Sonia .
INFLAMMATORY BOWEL DISEASES, 2019, 25 (03) :561-567
[48]   Crohn's disease and ulcerative colitis [J].
Burisch, Johan .
DANISH MEDICAL JOURNAL, 2014, 61 (01)
[49]   Risk of ulcerative colitis and Crohn's disease in smokers lacks causal evidence [J].
Pedersen, Kasper Monsted ;
Colak, Yunus ;
Vedel-Krogh, Signe ;
Kobylecki, Camilla Jannie ;
Bojesen, Stig Egil ;
Nordestgaard, Borge Gronne .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2022, 37 (07) :735-745
[50]   Risk of ulcerative colitis and Crohn’s disease in smokers lacks causal evidence [J].
Kasper Mønsted Pedersen ;
Yunus Çolak ;
Signe Vedel-Krogh ;
Camilla Jannie Kobylecki ;
Stig Egil Bojesen ;
Børge Grønne Nordestgaard .
European Journal of Epidemiology, 2022, 37 :735-745